EUVIMEDEUVIMED entdecken
Open Access

Pyrimethamine Inhibits Human Ovarian Cancer by Triggering Lethal Mitophagy via Activating the p38/JNK/ERK Pathway

Lingjuan Linghu, Hongying Zhou, Gang Zheng, Tao Yi

Oncology Research · 2025

DOI: 10.32604/or.2025.063724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Lingjuan Linghu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Wo…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Pyrimethamine, Mitophagy, MAP Kinase Signaling System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsPyrimethamineMitophagyMAP Kinase Signaling SystemFemaleHumansAnimalsMiceCell Line, TumorReactive Oxygen SpeciesMitochondriaXenograft Model Antitumor AssaysCell Proliferationp38 Mitogen-Activated Protein KinasesMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

P38/JNK/ERK pathwayPyrimethaminedrug repurposingmitophagyovarian cancer

Substanzen

PyrimethamineReactive Oxygen Speciesp38 Mitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, S…
  • Department of Human Anatomy, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, 610041, China.

Zitieren

APA

Linghu, L., Zhou, H., Zheng, G., & Yi, T. (2025). Pyrimethamine Inhibits Human Ovarian Cancer by Triggering Lethal Mitophagy via Activating the p38/JNK/ERK Pathway. Oncology Research. https://doi.org/10.32604/or.2025.063724

Vancouver

Linghu L, Zhou H, Zheng G, Yi T. Pyrimethamine Inhibits Human Ovarian Cancer by Triggering Lethal Mitophagy via Activating the p38/JNK/ERK Pathway. Oncology Research. 2025. doi:10.32604/or.2025.063724

BibTeX
@article{Linghu2025,
  author = {Linghu, Lingjuan and Zhou, Hongying and Zheng, Gang and Yi, Tao},
  title = {Pyrimethamine Inhibits Human Ovarian Cancer by Triggering Lethal Mitophagy via Activating the p38/JNK/ERK Pathway},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.063724}
}
Kostenlos starten →